Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples

BACKGROUND: Glioblastoma is a paradigm of cancer‐associated immunosuppression, limiting the effects of immunotherapeutic strategies. Thus, identifying the molecular mechanisms underlying immune surveillance evasion is critical. Recently, the preferential expression of inhibitory natural killer (NK)...

Descripción completa

Detalles Bibliográficos
Autores principales: Di, Wang, Fan, Wenhua, Wu, Fan, Shi, Zhongfang, Wang, Zhiliang, Yu, Mingchen, Zhai, You, Chang, Yuanhao, Pan, Changqing, Li, Guanzhang, Kahlert, Ulf Dietrich, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819299/
https://www.ncbi.nlm.nih.gov/pubmed/34881489
http://dx.doi.org/10.1111/cas.15236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819299/
https://www.ncbi.nlm.nih.gov/pubmed/34881489
http://dx.doi.org/10.1111/cas.15236

Ejemplares similares